Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year



Series A | Dead

Total Raised


Last Raised


About Culture Screening

Developer of antibiotics, anti-fungal drugs, and cancer drugs. The company develops products to address antimicrobial resistance through the exploitation of microbial genomics.

Culture Screening Headquarter Location

Studiestraede 4, 2

Holbaek, 4300,


45 3532 2058

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.